Louis St. L. O’dea

Biography

Dr. O’Dea earned his medical degree at University College Dublin, is board-certified in Internal Medicine and in Endocrinology and Metabolism in Canada and the United States, and completed his postgraduate medical training at McGill University and Massachusetts General Hospital, Harvard Medical School.Dr. Louis St. L. O’Dea is a board-certified physician with more than 20 years of industry experience, including a track record of successful global drug development and regulatory approvals. Dr. O’Dea has led 13 clinical NDAs, four orphan drug approvals, and one device approval, and he has experience with proteins, peptides, small molecules and nucleotides, as well as with a broad range of devices and routes of administration.Dr. O’Dea joined Akcea as Chief Medical Officer in January 2016. Prior to joining Akcea, Dr. O’Dea was Chief Medical Officer at Oxford Imunotec, overseeing Medical Affairs and Clinical Development. Prior to Oxford, he was Chief Medical Officer and Head of Regulatory Affairs at Moderna Therapeutics, a biotech company focused on developing messenger RNA-based therapeutics. Before Moderna, Dr. O’Dea was Chief Medical Officer at Radius Health, where he brought forward a number of molecules through clinical development, including Abaloparatide. Dr. O’Dea came to the biotech industry from an academic position at McGill University, beginning his pharmaceutical career with Serono where he played a major role in the successful development of their reproductive and metabolic portfolios. At Serono, he advanced through positions of increasing responsibility, including Chief Medical Officer for Japan and Oceania, and worldwide Head of Clinical Development for Endocrine and Metabolic products.

Research Interest

 His research interest in Business and Management and Medicine